Silicon Drugs & Intermediates Private Limited

Manufacturer of pharmaceutical and chemical products, established in 2011 with headquarters in Hyderabad.

2011 | Hyderabad, Telangana (India) | Active
Last Updated:

Silicon Drugs & Intermediates Profile

Key Indicators

  • Authorised Capital ₹ 3.30 Cr
  • Paid Up Capital ₹ 2.63 Cr
  • Company Age 14 Year, 8 Days
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 7.50 Cr
  • Revenue Growth -83.09%
  • Profit Growth 98.96%
  • Ebitda 99.62%
  • Net Worth -3.33%
  • Total Assets -16.37%

About Silicon Drugs & Intermediates

Silicon Drugs & Intermediates Private Limited (SDIPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 February 2011 and has a history of 14 years. Its registered office is in Hyderabad, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.30 Cr and a paid-up capital of Rs 2.63 Cr.

The company currently has active open charges totaling ₹7.50 Cr.

Siva Vuyyuru, Addanki Prasad, and Gade Reddy serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24100TG2011PTC072926

  • Company No.

    072926

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    25 Feb 2011

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

Who are the key members and board of directors at Silicon Drugs & Intermediates?

Board Members (3)

NameDesignationAppointment DateStatus
Addanki Prasad Country flag representing In Director 25-Feb-2011Current
Siva Vuyyuru Country flag representing In Director 25-Feb-2011Current
Gade Reddy Country flag representing In Director 25-Feb-2011Current

Financial Performance of Silicon Drugs & Intermediates.

Silicon Drugs & Intermediates Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 83.09% decrease. The company also saw a substantial improvement in profitability, with a 98.96% increase in profit. The company's net worth dipped by a decrease of 3.33%.

Silicon Drugs & Intermediates revenue growth over time
Silicon Drugs & Intermediates profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-83.09%
Revenue from Operations
-76.35%
Total Assets
-16.37%
Profit or Loss
98.96%
Net Worth
-3.33%
EBITDA
99.62%

What is the Ownership and Shareholding Structure of Silicon Drugs & Intermediates?

In 2021, Silicon Drugs & Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹7.50 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • State Bank Of India : 7.50 Cr

Latest Charge Details

DateLenderAmountStatus
16 May 2011State Bank Of India₹7.50 CrOpen

How Many Employees Work at Silicon Drugs & Intermediates?

Silicon Drugs & Intermediates has a workforce of 7 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Silicon Drugs & Intermediates Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Silicon Drugs & Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Silicon Drugs & Intermediates's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Silicon Drugs & Intermediates

Recent activity within the organization

  • Annual General Meeting

    Silicon Drugs & Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Silicon Drugs & Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.

  • Charges

    A charge with State Bank Of India amounted to Rs. 7.50 Cr with Charge ID 10295192 was registered on 16 May 2011.

  • Director Appointment

    Siva Nagi Reddy Vuyyuru was appointed as a Director was appointed as a Director on 25 Feb 2011 & has been associated with this company since 14 years 8 days .

  • Director Appointment

    Addanki Siva Rama Prasad was appointed as a Director was appointed as a Director on 25 Feb 2011 & has been associated with this company since 14 years 8 days .

  • Director Appointment

    Gade Bakki Reddy was appointed as a Director was appointed as a Director on 25 Feb 2011 & has been associated with this company since 14 years 8 days .

Frequently asked questions

  • What is the Incorporation or founding date of Silicon Drugs & Intermediates Private Limited?

    Silicon Drugs & Intermediates Private Limited was incorporated on 25 Feb 2011.

  • What is authorized share capital and paid-up capital of Silicon Drugs & Intermediates Private Limited?

    The authorized share capital of Silicon Drugs & Intermediates Private Limited is ₹ 3.30 Cr and paid-up capital is ₹ 2.63 Cr.

  • Who are the current board members & directors of Silicon Drugs & Intermediates Private Limited?

    Currently 3 directors are associated with Silicon Drugs & Intermediates Private Limited.

    • Siva Nagi Reddy Vuyyuru
    • Addanki Siva Rama Prasad
    • Gade Bakki Reddy

  • What is the registered address of Silicon Drugs & Intermediates Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Silicon Drugs & Intermediates Private Limited is H No. 2-52/2/24 Plot No 24 Sy 60 Megha Hills Colony, Guttalabegumpet (V) Serilingampa Lly India, Hyderabad, Telangana, 500081.

  • What is the corporate identification number (CIN) and company number of Silicon Drugs & Intermediates Private Limited?

    The corporate identification number (CIN) of Silicon Drugs & Intermediates Private Limited is U24100TG2011PTC072926 and the company number is 072926 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Silicon Drugs & Intermediates Private Limited?

    According to the financial reports for the fiscal year 2021, the revenue trend for Silicon Drugs & Intermediates Private Limited has fallen by -83.09%.

  • How many employees does Silicon Drugs & Intermediates Private Limited currently have?

    As Per 2021 financial reports, 7 employees are currently employed by Silicon Drugs & Intermediates Private Limited.

  • What change has been observed in the net worth of Silicon Drugs & Intermediates Private Limited, and by what percentage?

    The financial reports for the fiscal year 2021 indicates that The net worth of Silicon Drugs & Intermediates Private Limited has experienced an downturn of -3.33%.

  • What are the total open charges for Silicon Drugs & Intermediates Private Limited?

    As per the financial statements for fiscal Year 2021, The total open charges for Silicon Drugs & Intermediates Private Limited amount to ₹ 7.50 Cr.

  • When was the last Balance Sheet of Silicon Drugs & Intermediates Private Limited filed with the ROC?

    The most recent Balance Sheet for Silicon Drugs & Intermediates Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development